REQUEST A DEMO
Total
USD $0.00
Search more companies

MUP Centralinaya Apteka (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: MUP Centralinaya Apteka Profile Updated: August 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

MUP Centralinaya Apteka is a company in Russia, with a head office in Olenegorsk. The company operates in the Pharmacies and Drug Stores sector. It was established on December 10, 1992. In 2023, the company reported a net sales revenue drop of 15.76%. Its total assets decreased by 19.35% over the same period. The net profit margin of MUP Centralinaya Apteka increased by 0.32% in 2023.

Headquarters
Leningradskii, 4
Olenegorsk; Murmansk Oblast; Postal Code: 184533

Contact Details: Purchase the MUP Centralinaya Apteka report to view the information.

Basic Information
Outstanding Shares:
Purchase the MUP Centralinaya Apteka report to view the information.
Registered Capital:
Purchase the MUP Centralinaya Apteka report to view the information.
Incorporation Date:
December 10, 1992
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after MUP Centralinaya Apteka report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-15.76%
Total operating revenue
-15.76%
Operating profit (EBIT)
-4.07%
Net Profit (Loss) for the Period
38.12%
Total assets
-19.35%
Total equity
-50.22%
Operating Profit Margin (ROS)
-0.41%
Net Profit Margin
0.32%
Return on Equity (ROE)
-7.96%
Quick Ratio
-0.06%
Cash Ratio
-0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?